{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:03:33Z","timestamp":1767146613166,"version":"build-2238731810"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T00:00:00Z","timestamp":1558742400000},"content-version":"vor","delay-in-days":144,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/j.lrr.2019.100172","type":"journal-article","created":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T10:51:00Z","timestamp":1558781460000},"page":"100172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Atypical chronic myeloid leukemia BCR-ABL 1 negative: A case report and literature review"],"prefix":"10.1016","volume":"12","author":[{"given":"Jihane","family":"Belkhair","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2385-5795","authenticated-orcid":false,"given":"Abderahim","family":"Raissi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hicham","family":"Elyahyaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustapha Ait","family":"Ameur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Chakour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lrr.2019.100172_bib0001","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1182\/asheducation-2011.1.264","article-title":"Myelodysplastic\/myeloproliferative neoplasms. hematology","volume":"2011","author":"Cazzola","year":"2011","journal-title":"Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.lrr.2019.100172_bib0002","series-title":"Atlas of Hematopathology Morphology, Immunophenotype, Cytogenetics, and Molecular Approaches","author":"Faramarz","year":"2013"},{"issue":"20","key":"10.1016\/j.lrr.2019.100172_bib0003","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood J."},{"issue":"3","key":"10.1016\/j.lrr.2019.100172_bib0004","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.beha.2005.07.001","article-title":"Classification of chronic myeloid disorders: from Dameshek towards a semi-molecular system","volume":"19","author":"Efferi","year":"2006","journal-title":"Best Pract. Res. Clin. Haematol."},{"issue":"1","key":"10.1016\/j.lrr.2019.100172_bib0005","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ng.2495","article-title":"Recurrent SETBP1 mutations in atypical chronic myeloid leukemia","volume":"45","author":"Piazza","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.lrr.2019.100172_bib0006","series-title":"Blood and Bone Marrow Pathology","author":"Czader","year":"2011"},{"issue":"October, 8","key":"10.1016\/j.lrr.2019.100172_bib0007","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/cncr.10832","article-title":"Characteristics and outcome of patients with Philadelphia chromosome negative, bcr\/abl negative chronic myelogenous leukemia","volume":"95","author":"Onida","year":"2002","journal-title":"Cancer"},{"issue":"December, 12","key":"10.1016\/j.lrr.2019.100172_bib0008","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/sj.bmt.1704686","article-title":"Outcome of hematopoietic stem cell transplantation in patients with atypical chronic myeloid leukemia","volume":"34","author":"Koldehoff","year":"2004","journal-title":"Bone Marrow Transpl."},{"issue":"June, 3 Suppl 9","key":"10.1016\/j.lrr.2019.100172_bib0009","first-page":"1","article-title":"Mechanism of action of hydroxyurea","volume":"19","author":"Yarbro","year":"1992","journal-title":"Semin. Oncol"},{"issue":". March, 3","key":"10.1016\/j.lrr.2019.100172_bib0010","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1634\/theoncologist.10-3-176","article-title":"FDA drug approval summary: azacitidine (5-azacytidine, Vidaza) for injectable suspension","volume":"10","author":"Kaminskas","year":"2005","journal-title":"Oncologist"}],"updated-by":[{"DOI":"10.1016\/j.lrr.2022.100310","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000}}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048918300797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048918300797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:07:57Z","timestamp":1761959277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213048918300797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":10,"alternative-id":["S2213048918300797"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2019.100172","relation":{},"ISSN":["2213-0489"],"issn-type":[{"value":"2213-0489","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atypical chronic myeloid leukemia BCR-ABL 1 negative: A case report and literature review","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2019.100172","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100172"}}